Reduced HIV-1 infectability of CD4+ lymphocytes from exposed-uninfected individuals:: Association with low expression of CCR5 and high production of β-chemokines

被引:132
作者
Paxton, WA
Liu, R
Kang, S
Wu, LJ
Gingeras, TR
Landau, NR
Mackay, CR
Koup, RA
机构
[1] Rockefeller Univ, Aaron Diamond AIDS Res Ctr, New York, NY 10016 USA
[2] LeukoSite Inc, Cambridge, MA 02142 USA
[3] Affymetrix Inc, Santa Clara, CA 95051 USA
关键词
D O I
10.1006/viro.1998.9082
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
We examined the human immunodeficiency virus type 1 infectability of CD4(+) lymphocytes isolated from CCR5 wild-type individuals, individuals heterozygous for the Delta 32 allele of CCR5, and HIV-l-exposed but uninfected (EU) individuals who had CD4(+) lymphocytes refractory to M-tropic viral replication. None of the EU individuals were found to be heterozygous for the Delta 32 allele. The CD4(+) lymphocytes isolated from CCR5/Delta 32 and EU individuals were less infectable with an M-tropic viral isolate of HIV-1 than CCR5/CCR5 control individuals but were equally as infectable with a T-tropic viral isolate. The restriction to M-tropic viral isolate replication did not associate with any profound genotypic change in the CCR5 gene. CD4(+) lymphocytes from CCR5/Delta 32 and CCR5/CCR5 EU individuals were more sensitive to the HIV-inhibitory effects of the recombinant beta-chemokines RANTES, MIP-1 alpha, and MIP-1 beta than were CD4(+) lymphocytes from CCR5/CCR5 control individuals. CD4(+) lymphocytes from EU individuals also showed increased sensitivity to recombinant beta-chemokines and low surface expression of CCR5. A phenotype of low CCR5 expression and high secretion of beta-chemokines is associated with reduced infectability of cells by M-tropic HIV-1. This phenotype may also be associated with protection against sexual transmission of HIV-1. (C) 1998 Academic Press.
引用
收藏
页码:66 / 73
页数:8
相关论文
共 26 条
  • [21] Contrasting genetic influence of CCR2 and CCR5 variants on HIV-1 infection and disease progression
    Smith, MW
    Dean, M
    Carrington, M
    Winkler, C
    Huttley, GA
    Lomb, DA
    Goedert, JJ
    OBrien, TR
    Jacobson, LP
    Kaslow, R
    Buchbinder, S
    Vittinghoff, E
    Vlahov, D
    Hoots, K
    Hilgartner, MW
    OBrien, SJ
    [J]. SCIENCE, 1997, 277 (5328) : 959 - 965
  • [22] Theodorou I, 1997, LANCET, V349, P1219
  • [23] Genetic restriction of AIDS pathogenesis by an SDF-1 chemokine gene variant
    Winkler, C
    Modi, W
    Smith, MW
    Nelson, GW
    Wu, XY
    Carrington, M
    Dean, M
    Honjo, T
    Tashiro, K
    Yabe, D
    Buchbinder, S
    Vittinghoff, E
    Goedert, JJ
    O'Brien, TR
    Jacobson, LP
    Detels, R
    Donfield, S
    Willoughby, A
    Gomperts, E
    Vlahov, D
    Phair, J
    O'Brien, SJ
    [J]. SCIENCE, 1998, 279 (5349) : 389 - 393
  • [24] CCR5 levels and expression pattern correlate with infectability by macrophage-tropic HIV-1, in vitro
    Wu, LJ
    Paxton, WA
    Kassam, N
    Ruffing, N
    Rottman, JB
    Sullivan, N
    Choe, H
    Sodroski, J
    Newman, W
    Koup, RA
    Mackay, CR
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 185 (09) : 1681 - 1691
  • [25] Interaction of chemokine receptor CCR5 with its ligands: Multiple domains for HIV-1 gp120 binding and a single domain for chemokine binding
    Wu, LJ
    LaRosa, G
    Kassam, N
    Gordon, CJ
    Heath, H
    Ruffing, N
    Chen, H
    Humblias, J
    Samson, M
    Parmentier, M
    Moore, JP
    Mackay, CR
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 186 (08) : 1373 - 1381
  • [26] Inherited resistance to HIV-1 conferred by an inactivating mutation in CC chemokine receptor 5: Studies in populations with contrasting clinical phenotypes, defined racial background, and quantified risk
    Zimmerman, PA
    BucklerWhite, A
    Alkhatib, G
    Spalding, T
    Kubofcik, J
    Combadiere, C
    Weissman, D
    Cohen, O
    Rubbert, A
    Lam, G
    Vaccarezza, M
    Kennedy, PE
    Kumaraswami, V
    Giorgi, JV
    Detels, R
    Hunter, J
    Chopek, M
    Berger, EA
    Fauci, AS
    Nutman, TB
    Murphy, PM
    [J]. MOLECULAR MEDICINE, 1997, 3 (01) : 23 - 36